central bank digital currency news- Top Block

Jialiqi: It is planned to distribute a cash dividend of RMB 2.8 yuan every 10 shares. Jialiqi announced that it plans to distribute a cash dividend of RMB 2.8 yuan to all shareholders every 10 shares based on the company's existing total share capital of 82,975,500 shares, with a total cash dividend of RMB 23,233,100, accounting for 29.56% of the company's net profit attributable to shareholders of listed companies in the first three quarters of 2024. No bonus shares will be paid this time, and the capital reserve fund will not be converted into share capital, and the remaining undistributed profits will be carried forward to the next year.Mercedes-Benz Group Co., Ltd. announced the personnel changes of the board of directors, and the Board of Supervisors of Mercedes-Benz Group Co., Ltd. decided the personnel changes of the board of directors. In 2025, Hubertus Troska, Sabine Kohleisen and Renata Jungo Brüngger, members of the board of directors of Mercedes-Benz Group, will retire after the contract expires. At the same time, the Board of Supervisors decided to appoint Oliver Thöne, Mathias Geisen and Olaf Schick as new board members.South Korean Finance Minister and US Treasury Secretary Yellen confirmed that they will work closely together.

Market information: Nissan will appoint JÉRÉMIE PAPIN as the chief financial officer on Wednesday.Liaoning Energy: Guo Hongbo, the chairman of the board of directors, resigned due to job change. Liaoning Energy (600758) announced on the evening of December 11th that Guo Hongbo applied to resign as the chairman, director and all the special committees under the board of directors due to job change. After resigning, Guo Hongbo no longer holds any position in the company.US Treasury Department: US Treasury Secretary Yellen expressed appreciation for the close communication between the Ministry of Economic Affairs of Korea and the United States after the recent events in South Korea.

Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.Kei Ma quit Xiaomi Home Technology Co., Ltd., and Tianyancha App showed that recently, Xiaomi Home Technology Co., Ltd. underwent industrial and commercial changes, and Kei Ma stepped down as the legal representative and manager. As Peng took over, Lei Jun was changed from an executive director to a director. Xiaomi Home Technology Co., Ltd. was established in January 2017 with a registered capital of RMB 80 million. Its business scope includes communication equipment sales, computer software and hardware and auxiliary equipment wholesale, computer software and hardware and auxiliary equipment retail, shoes and hats wholesale, motorcycles and spare parts wholesale, etc. It is wholly owned by Xiaomi Communication Technology Co., Ltd. According to media reports, recently, Kei Ma, vice president of Xiaomi Group, has left his post, and the news has aroused many concerns.Expert: Central enterprises will continue to recruit in A-shares. On the evening of December 9, Huada Jiutian, a domestic EDA leader, announced that China Electronic Information Industry Group Co., Ltd. will become the actual controller of the company. So far, the number of A-share listed companies "incorporated" by central enterprises reached 10 in 2024. The end of 2024 is an important node for central enterprises to optimize the layout of listed platforms. The Work Plan for Improving the Quality of Listed Companies Controlled by Central Enterprises previously issued by the State-owned Assets Supervision and Administration Commission of the State Council made it clear that the adjustment and revitalization of the listing platform should be basically completed by the end of 2024, and it is supported to revitalize through absorption and merger, asset restructuring and cross-market operation, or to withdraw through free transfer and equity transfer, so as to further focus on the main business and advantageous areas. Looking forward to the next layout rhythm of central enterprises in the capital market, many experts interviewed by reporters believe that the pace of "recruiting" of central enterprises in A shares will continue. In the coming period, the cases of central enterprises strengthening their main business through capital operation and giving play to their strategic support and industrial leading functions will be on the rise. (shanghai securities news)